Transcription of Title: Protocol for Continuous Morphine Infusion
{{id}} {{{paragraph}}}
DOCUMENT CONTROL PAGE. title : Protocol for Continuous Morphine Infusion title Version: 4. Reference Number: Supersedes Supersedes: Version 3 (2009). Significant Changes: Additional requirements for oncology patients Originated By: (1) Dr. R Walker, (2) Dr. D Patel, (3) Dot Lowthian, (4) Denise Jonas, (5). Originator or Annette Adams modifier Designation:(1) and (2) Consultant Paediatric Anaesthetists and Lead Clinicians Pain Management, (3) Lead Practitioner Pain Management - Nursing (4) Lecturer/Practitioner - Nursing, (5) Principal Pharmacist (6) Senior Clinical Pharmacist Modified by: (2) Dr. D. Patel, (3) Dot Lowthian (6) Adam Sutherland Designation: (2) Consultant Paediatric Anaesthetist and Lead Clinician Pain management, (3) Lead Practitioner (6) Senior Clinical Pharmacist Ratification Referred for approval by: Children's Medicines Management Committee Date of Referral: January 2011.
RMCH Paediatric Pain Team Protocol Page 4 of 4 Protocol for Continuous Morphine Infusion Version Number: 3 (January 2011) 1.6 Monitoring Rate and dosage is adjusted according to …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
New Haven Hospital ICU Insulin Infusion, Glucose, Cymevene, Infusion, The Administration of Intravenous Vancomycin, The Administration of Intravenous Vancomycin in, Diabetes Medical Management Plan, 128 Diabetic Ketoacidosis, DIABETIC KETOACIDOSIS, B4. PHARMACISTS ELECTROLYTE MANAGEMENT IN ADULT, For the Child with Type 1 Diabetes